Anti-Interferon beta antibody
5
(1 Review)
|
(9 Publications)
Rabbit Polyclonal Interferon beta antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 9 publications.
View Alternative Names
IFB, IFNB, IFNB1, Interferon beta, IFN-beta, Fibroblast interferon
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Interferon beta antibody (AB85803)
ICC/IF image of ab85803 stained HepG2 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab85803, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899 Dylight 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- WB
Unknown
Western blot - Anti-Interferon beta antibody (AB85803)
The Interferon Beta protein sequence contains both a phosphorylation and a glycosylation site (Swissprot). Post-translation modifications could account for the migration of the band at a higher molecular weight than predicted.
All lanes:
Western blot - Anti-Interferon beta antibody (ab85803) at 1 µg/mL
Lane 1:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
Western blot - WI-38 whole cell lysate (<a href='/en-us/products/cell-lysates/wi-38-whole-cell-lysate-ab3960'>ab3960</a>) at 10 µg
Lane 3:
Human liver tissue lysate - total protein (<a href='/en-us/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg
Lane 4:
Lung (Human) Tissue Lysate at 10 µg
Lane 5:
Human kidney tissue lysate - total protein (<a href='/en-us/products/unavailable/human-kidney-tissue-lysate-total-protein-ab30203'>ab30203</a>) at 10 µg
Lane 6:
Human spleen tissue lysate - total protein (<a href='/en-us/products/unavailable/human-spleen-tissue-lysate-total-protein-ab29699'>ab29699</a>) at 10 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 22 kDa
Observed band size: 110 kDa,120 kDa,160 kDa,30 kDa,37 kDa
true
Exposure time: 20min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Interferon beta functions as an important mediator of immune functions regulating the activity of natural killer cells and macrophages. It also boosts antigen presentation to T cells. Interferon beta belongs to the larger family of interferons which includes IFN-alpha and IFN-gamma each having distinct effects but working together to mount an effective immune response. Though it does not form part of a complex it plays a critical standalone role in immune signaling pathways.
Pathways
Interferon beta associates strongly with the JAK-STAT signaling pathway. Upon activation it interacts with receptors to phosphorylate STAT proteins mainly STAT1 and STAT2 which then dimerize and translocate to the nucleus to trigger gene expression. Another important pathway is the antiviral response where interferon beta modulates the expression of hundreds of interferon-stimulated genes. These pathways intricately involve other proteins like IFN-alpha and IFN-gamma which work synergistically to establish an effective antiviral environment.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Journal for immunotherapy of cancer 12: PubMed38749537
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 129:1852-1862 PubMed37838813
2023
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 64:19 PubMed36692471
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed35485288
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:741502 PubMed34671355
2021
Applications
Unspecified application
Species
Unspecified reactive species
bioRxiv : the preprint server for biology : PubMed34268510
2021
Applications
Unspecified application
Species
Unspecified reactive species
Allergy, asthma & immunology research 12:994-1011 PubMed32935491
2020
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 10:9032-9049 PubMed32802177
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:10203 PubMed29976933
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com